Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants
Clinical trial NCT01180790 · COMPLETED
Trial details
- NCT number
- NCT01180790
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-03-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.